Skip to main content
See every side of every news story
Published loading...Updated

University of Oxford Vaccinates First Participant in World-First Trial

Summary by Oxford Mail
Researchers from the Oxford Vaccine Group administered the dose in the first clinical trial of a vaccine targeting the Bundibugyo ebolavirus.

6 Articles

Lean Left

The first volunteer on Friday received a dose of a new experimental vaccine against the Bundibugyo strain that is causing a deadly Ebola outbreak in the Democratic Republic of Congo. The Ebola outbreak has already claimed more than a thousand lives in the Democratic Republic of Congo and Uganda.

·Ljubljana, Slovenia
Read Full Article

The clinical trial conducted by the University of Oxford takes place at a time when the epidemic has already killed 1,300 people in the Democratic Republic of the Congo.

A first volunteer was vaccinated with a specific experimental vaccine against Bundibugyo strains of the Ebola virus, which killed over 1,000 people in the Democratic Republic of Congo (DRC) and Uganda, Oxford University reports.

·Bucharest, Romania
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 67% of the sources lean Left
67% Left

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Stirile Pro TV broke the news in Bucharest, Romania on Saturday, July 25, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal